BioMag laboratory, Helsinki University Central Hospital
Helsinki, Uusimaa, 00029, Finland
NCT Number: NCT04101916
The investigators have recently shown in incomplete SCI patients that long-term paired associative stimulation is capable of restoring voluntary control over some paralyzed muscles and enhancing motor output in the weak muscles. In this study, the investigators will administer long-term paired associative stimulation to patients with incomplete cervical level SCI at the subacute stage, and investigate its effectiveness for upper extremity rehabilitation.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Helsinki, Uusimaa, 00029, Finland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Paired associative stimulation (PAS) administered several times per week for 12 weeks to upper limbs. PAS comprises transcranial magnetic stimulation (eXimia magnetic stimulator, Nexstim Ltd, Helsinki, Finland) and peripheral nerve stimulation (given with Dantec Keypoint® electroneuromyography device (Natus Medical Incorporated, Pleasanton, CA, USA)).
Sham transcranial magnetic stimulation and sham peripheral nerve stimulation.
Time frame: Change from baseline score immediately after, 6 months after and 1 year after last stimulation session
hand muscle strength is evaluated on 0-5 scale (0=no movement, 5=normal)
Time frame: Change from baseline score immediately after, 6 months after and 1 year after last stimulation session
standard SCIM evaluation
Helsinki University Central Hospital
Other
Paired Associative Stimulation in Subacute Spinal Cord Injury
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03922802
Central Nervous System Diseases, Hypoxia
Chicago, Illinois, United States
View Trial DetailsNCT05530798
Back Injuries, Bone Diseases
Charleston, South Carolina, United States
View Trial DetailsNCT05870189
Central Nervous System Diseases, Nervous System Diseases
Minneapolis, Minnesota, United States
View Trial DetailsNCT03459885
Central Nervous System Diseases, Nervous System Diseases
Helsinki, Uusimaa, Finland
View Trial Details